What is CJC-1295 + Ipamorelin?

What is CJC-1295 + Ipamorelin?

CJC-1295 is a GHRH (growth-hormone-releasing hormone) analogue and Ipamorelin is a selective GH secretagogue (ghrelin-receptor agonist). Combined, they drive a stronger, cleaner growth-hormone pulse than either alone. Supplied for research as one pre-filled multi-dose pen.

The pairing is studied for growth-hormone-axis support in recovery and body-composition research. Ipamorelin is favoured for its selectivity — little effect on cortisol or prolactin. Research outcomes vary with dose and timing.

Reported side effects

• Transient facial flushing or a head-rush shortly after injection.
• Water retention, tingling or numbness in the hands (GH-axis related), usually dose-dependent.
• Mild, transient injection-site reactions.

How to dose CJC-1295 + Ipamorelin

Roughly 100 mcg of each peptide per dose, one to three times daily on an empty stomach — often before bed to align with natural GH release. The combined pen doses both peptides together, so no separate mixing is needed.

How to get CJC-1295 + Ipamorelin

The Body Pharm CJC-1295 + Ipamorelin pen is a sealed, HPLC-tested device with a published Certificate of Analysis and free, discreet UK delivery. Sold strictly for research use only.

Cost per month

From £110 per pen — one pen covers a multi-week research cycle at once-daily dosing.